BIOSTAR PHARM-B (02563): Court Approves Company's Application to Appoint Receiver for Sub-Fund; Company Contacts Receiver to Advance Process

Stock News

2025/12/11

BIOSTAR PHARM-B (02563) announced that the Grand Court of the Cayman Islands (Financial Services Division) ruled on December 3, 2025, approving the company's application to appoint a receiver for the sub-fund LFM Stable Income Fund SP. The court recognized US-Biostar as a creditor under the terms of the subscription letter. The company's legal counsel has communicated with the appointed receiver, who will initiate liquidation petitions and receivership procedures for LFM Fund in accordance with Cayman Islands law. On December 10, 2025, the company contacted the receiver to advance the receivership process.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1180194174"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180194174\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180194174?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-11 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180194174","market":"hk","top_or_hot":-1,"title":"BIOSTAR PHARM-B (02563): Court Approves Company's Application to Appoint Receiver for Sub-Fund; Company Contacts Receiver to Advance Process","media":"Stock News","content":"<p>BIOSTAR PHARM-B (02563) announced that the Grand Court of the Cayman Islands (Financial Services Division) ruled on December 3, 2025, approving the company's application to appoint a receiver for the sub-fund LFM Stable Income Fund SP. The court recognized US-Biostar as a creditor under the terms of the subscription letter. The company's legal counsel has communicated with the appointed receiver, who will initiate liquidation petitions and receivership procedures for LFM Fund in accordance with Cayman Islands law. On December 10, 2025, the company contacted the receiver to advance the receivership process.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIOSTAR PHARM-B (02563): Court Approves Company's Application to Appoint Receiver for Sub-Fund; Company Contacts Receiver to Advance Process</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIOSTAR PHARM-B (02563): Court Approves Company's Application to Appoint Receiver for Sub-Fund; Company Contacts Receiver to Advance Process\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-12-11 22:58</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BIOSTAR PHARM-B (02563) announced that the Grand Court of the Cayman Islands (Financial Services Division) ruled on December 3, 2025, approving the company's application to appoint a receiver for the sub-fund LFM Stable Income Fund SP. The court recognized US-Biostar as a creditor under the terms of the subscription letter. The company's legal counsel has communicated with the appointed receiver, who will initiate liquidation petitions and receivership procedures for LFM Fund in accordance with Cayman Islands law. On December 10, 2025, the company contacted the receiver to advance the receivership process.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"","article_id":"1180194174","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180194174","pubTimestamp":1765465094,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BIOSTAR PHARM-B (02563) announced that the Grand Court of the Cayman Islands (Financial Services Division) ruled on December 3, 2025, approving the company's application to appoint a receiver for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1515":"抗疫概念","02563":"华昊中天医药-B","BK1161":"生物科技","BK1574":"生物医药B类股","09939":"开拓药业-B"},"translate_title":"BIOSTAR PHARM-B(02563)：法院批准公司委任子基金接管人的申请；公司联系接收方以推进流程","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"02563":1,"09939":1},"content_text":"BIOSTAR PHARM-B (02563) announced that the Grand Court of the Cayman Islands (Financial Services Division) ruled on December 3, 2025, approving the company's application to appoint a receiver for the sub-fund LFM Stable Income Fund SP. The court recognized US-Biostar as a creditor under the terms of the subscription letter. The company's legal counsel has communicated with the appointed receiver, who will initiate liquidation petitions and receivership procedures for LFM Fund in accordance with Cayman Islands law. On December 10, 2025, the company contacted the receiver to advance the receivership process.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}